Stock Research: Santen Pharmaceutical

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Santen Pharmaceutical

TSE:4536 JP3336000009
86
  • Value
    72
  • Growth
    26
  • Safety
    Safety
    67
  • Combined
    57
  • Sentiment
    92
  • 360° View
    360° View
    86
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

SANTEN PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company focused on the research, development, manufacturing, and sales of pharmaceutical products. It operates in medical pharmaceutical, OTC drugs, medical devices, and other businesses, including the cleaning business. The company operates in Japan, Europe, Asia, and North America markets. In the last fiscal year, the company had 3849 employees, a market cap of $3814 million, profits of $1141 million, and revenue of $2001 million.

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
72 72 70 77
Growth
26 20 51 43
Safety
Safety
67 61 80 84
Sentiment
92 58 70 27
360° View
360° View
86 55 94 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
52 65 39 31
Opinions Change
81 59 82 50
Pro Holdings
n/a 40 100 37
Market Pulse
75 56 26 47
Sentiment
92 58 70 27
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
72 72 70 77
Growth
26 20 51 43
Safety Safety
67 61 80 84
Combined
57 50 90 82
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
78 76 63 78
Price vs. Earnings (P/E)
64 63 62 59
Price vs. Book (P/B)
38 45 56 67
Dividend Yield
74 72 76 88
Value
72 72 70 77
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
21 4 8 16
Profit Growth
34 58 94 96
Capital Growth
62 23 23 43
Stock Returns
42 46 79 37
Growth
26 20 51 43
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
61 54 63 74
Refinancing
50 44 63 61
Liquidity
72 64 76 84
Safety Safety
67 61 80 84

Similar Stocks

Discover high‑ranked alternatives to Santen Pharmaceutical and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

Megmilk Snow Brand

TSE:2270
Country: Japan
Industry: Packaged Foods & Meats
Size: Medium
Full Stock Analysis

Alfresa Holdings

TSE:2784
Country: Japan
Industry: Health Care Distributors
Size: Large
Full Stock Analysis

Kyudenko

TSE:1959
Country: Japan
Industry: Construction & Engineering
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

The stock offers good value, safe financing, and positive sentiment. However, it has below-average growth expectations. It is well-suited for conservative buy-and-hold investors who prioritize stability and low valuation over growth.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: